Alliances and Multi-Stakeholder Collaborations

GSA is known as a convener, collaborator, connector, communicator, and catalyzer in addressing pivotal issues in how we age. Through our Corporate Leaders Forum and collaboration with our members, GSA has provided venues for interdisciplinary and multi-stakeholder dialogue that has helped to advance our understanding of aging and how we care for our older adult population. Members of our Forum work strategically with the Society to address a range of issues impacting aging research, education, practice, and the business of care.

Notable Forum member collaborations include:

Being a member of the GSA Corporate Leaders Forum benefits our members, their companies, and the field of gerontology by providing access to vital information and opportunities for active participation in the Society initiatives that align with their mission. Support from our Forum members is invested in GSA programs that focus on impactful strategies to improve the care of older adults and to stimulate dialogue on issues that advance opportunities for all of us to have meaning as we age.

There are many benefits of Corporate Leaders Forum membership:

  1. Invitation to four annual Forum meetings
  2. Access to all GSA peer-reviewed, high impact publications and newsletters
  3. Access to GSA Connect, the networking communication of GSA members
  4. Recognition in Gerontology News, on www.geron.org and at the GSA Annual Scientific Meeting opening general session, on signage and in all program materials
  5. Registration to the GSA Annual Scientific Meeting
  6. Invitation to the GSA Leadership Reception held during the GSA Annual Scientific Meeting

If you are interested in becoming a Corporate Leaders Forum member, please contact Jen Pettis at This email address is being protected from spambots. You need JavaScript enabled to view it..

Current supporters include:

AbbottAcadiaavanirbankofamericacolgatepalmoliveeisai   eisaiglaxosmithklineHaleonjohnsonandjohnsonjohnsonandjohnsonmerck   nestlenovavaxotsuka2021pfizersanofiseqirus